title: Generic Drug Approvals Since the 1984 Hatch-Waxman Act.
authors.affiliation: Yale University School of Medicine, New Haven, Connecticut.
authors.forename: Ravi
authors.initials: R
authors.lastname: Gupta
authors.affiliation: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Aaron S
authors.initials: AS
authors.lastname: Kesselheim
authors.affiliation: Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts4Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Downing
authors.affiliation: Departments of Medicine and the History of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
authors.forename: Jeremy
authors.initials: J
authors.lastname: Greene
authors.affiliation: Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut6Section of General Internal Medicine and the Robert Wood Johnson Foundation Clinical Scholars Program, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut7Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut.
authors.forename: Joseph S
authors.initials: JS
authors.lastname: Ross
mesh_terms: D000970:Antineoplastic Agents; D016208:Databases, Factual; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D016568:Drugs, Generic; D006801:Humans; D011619:Psychotropic Drugs; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic; D011619:Psychotropic Drugs